“Catherine Szyman Chooses to Utilize $2.32M in Options at Edwards Lifesciences” – Reported by Benzinga
Catherine Szyman, the Chief Operating Officer of Edwards Lifesciences, a leading global medical technology company, has recently decided to exercise options worth $2.32 million. This …